4-(2-Amino-4-methyl-1,3-thiazol-5-yl)-n-[4-(morpholin-4-yl)phenyl]-2,5-dihydropyrimidin-2-imine (CHEM103507)
| Record Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||
| Creation Date | 2026-04-05 13:59:48 UTC | ||||||||
| Update Date | 2026-05-14 18:55:33 UTC | ||||||||
| Accession Number | CHEM103507 | ||||||||
| Identification | |||||||||
| Common Name | 4-(2-Amino-4-methyl-1,3-thiazol-5-yl)-n-[4-(morpholin-4-yl)phenyl]-2,5-dihydropyrimidin-2-imine | ||||||||
| Class | Small Molecule | ||||||||
| Description | 4-(2-Amino-4-methyl-1,3-thiazol-5-yl)-n-[4-(morpholin-4-yl)phenyl]-2,5-dihydropyrimidin-2-imine belongs to the morpholines, a subclass of oxazinanes within the organic compounds. This organoheterocyclic compound has the chemical formula C18H20N6OS and an average molecular weight of 368.46 g/mol. In terms of biological activity, two protein targets have been recorded for this compound: Cyclin-dependent kinase 2 (CDK2) and Cyclin-A2 (CCNA2). | ||||||||
| Contaminant Sources | Not Available | ||||||||
| Contaminant Type | Not Available | ||||||||
| Chemical Structure |  | ||||||||
| Synonyms | Not Available | ||||||||
| Chemical Formula | C18H20N6OS | ||||||||
| Average Molecular Mass | 368.456 g/mol | ||||||||
| Monoisotopic Mass | 368.142 g/mol | ||||||||
| CAS Registry Number | 1059105-22-4 | ||||||||
| IUPAC Name | 4-methyl-5-[(2Z)-2-{[4-(morpholin-4-yl)phenyl]imino}-2,5-dihydropyrimidin-4-yl]-1,3-thiazol-2-amine | ||||||||
| Traditional Name | Not Available | ||||||||
| SMILES | CC1=C(SC(N)=N1)C1=N\C(=N/C2=CC=C(C=C2)N2CCOCC2)N=CC1 | ||||||||
| InChI Identifier | InChI=1S/C18H20N6OS/c1-12-16(26-17(19)21-12)15-6-7-20-18(23-15)22-13-2-4-14(5-3-13)24-8-10-25-11-9-24/h2-5,7H,6,8-11H2,1H3,(H2,19,21)/b22-18- | ||||||||
| InChI Key | RPSZSAKYXPWBRR-PYCFMQQDSA-N | ||||||||
| Chemical Taxonomy | |||||||||
| Classification | Not classified | ||||||||
| Biological Properties | |||||||||
| Status | Detected and Not Quantified | ||||||||
| Origin | Not Available | ||||||||
| Cellular Locations | Not Available | ||||||||
| Biofluid Locations | Not Available | ||||||||
| Tissue Locations | Not Available | ||||||||
| Pathways | Not Available | ||||||||
| Applications | Not Available | ||||||||
| Biological Roles | Not Available | ||||||||
| Chemical Roles | Not Available | ||||||||
| Physical Properties | |||||||||
| State | Not Available | ||||||||
| Appearance | Not Available | ||||||||
| Experimental Properties |
| ||||||||
| Predicted Properties | Not Available | ||||||||
| Spectra | |||||||||
| Spectra |
| ||||||||
| Toxicity Profile | |||||||||
| Route of Exposure | Not Available | ||||||||
| Mechanism of Toxicity | Not Available | ||||||||
| Metabolism | Not Available | ||||||||
| Toxicity Values | Not Available | ||||||||
| Lethal Dose | Not Available | ||||||||
| Carcinogenicity (IARC Classification) | Not Available | ||||||||
| Uses/Sources | Not Available | ||||||||
| Minimum Risk Level | Not Available | ||||||||
| Health Effects | Not Available | ||||||||
| Symptoms | Not Available | ||||||||
| Treatment | Not Available | ||||||||
| Concentrations | |||||||||
| Not Available | |||||||||
| External Links | |||||||||
| Identifiers | Not Available | ||||||||
| References | |||||||||
| Synthesis Reference | Not Available | ||||||||
| MSDS | Not Available | ||||||||
| General References | Not Available | ||||||||
